13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Arecoline induces epithelial mesenchymal transition in HK2 cells by upregulating the ERK-mediated signaling pathway.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Arecoline, a component of betel nuts, is a known carcinogen that causes oral cancers among those who chew betel nuts. Betel nut chewing is also associated with an increased risk of chronic kidney disease (CKD), but the role of arecoline in this association is unclear. This in vitro study investigates the effects of arecoline on cultured human kidney (HK2) cells. We observed that arecoline had no effect on cell viability but increased cell migration in a dose-dependent manner. Western blot analysis showed that arecoline treatment caused a dose-dependent decrease in E-cadherin expression and dose-dependent increases in N-cadherin, vimentin, α-SMA, and collagen expression; reverse transcriptase-polymerase chain reaction analysis revealed dose-dependent increases in α-SMA and collagen mRNA. Arecoline treatment upregulated the expression of phosphorylated extracellular signal-regulated kinase through epithelial mesenchymal transition and renal fibrosis in HK2 cells. These findings demonstrate that arecoline plays a role in inducing the epithelial mesenchymal transition and fibrogenesis in renal tubule cells and suggest that arecoline promotes the progression of CKD.

          Related collections

          Author and article information

          Journal
          Environ Toxicol
          Environmental toxicology
          Wiley
          1522-7278
          1520-4081
          Sep 2020
          : 35
          : 9
          Affiliations
          [1 ] Department of Biochemistry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
          [2 ] Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
          [3 ] Clinical laboratory, Chung Shan Medical University Hospital, Taichung, Taiwan.
          [4 ] Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.
          [5 ] Department of Medicine Research, Buddhist Dalin Tzu Chi Hospital, Chiayi, Taiwan.
          [6 ] Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan.
          [7 ] Division of Pediatric Surgery, Department of Surgery, Children's Hospital of China Medical University, Taichung, Taiwan.
          [8 ] School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.
          [9 ] School of Medicine, Tzu Chi University, Hualien, Taiwan.
          Article
          10.1002/tox.22937
          32441858
          d98579ef-e05c-4403-88b3-e41bfb12c6a8
          History

          epithelial mesenchymal transition,chronic kidney disease,arecoline,ERK

          Comments

          Comment on this article